MedTrace Logo

Performance Comparison Between Masimo W1™ and Apple Watch Series 8

NCT05968079 · Status: COMPLETED · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-04-09

Study results available
· View outcomes & findings →

Summary

This study is also designed to compare the performance of Masimo W1™ and Apple Watch Series 8 against FDA cleared hospital grade pulse oximetry technology under desaturation conditions.

Conditions

  • Healthy Volunteers

Interventions

DEVICE

Masimo W1™ and Apple Watch Series 8

Noninvasive wearable health monitoring device

Sponsors & Collaborators

  • Masimo Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-06
Primary Completion
2023-10-11
Completion
2023-10-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05968079 on ClinicalTrials.gov